Atlas Venture Life Science Advisors, LLC
CIK: 0001917529SEC EDGAR →
Portfolio Value
$865.2M
Holdings
8
As of
Q4 2025
New Positions
1
Closed Positions
2
Top 10 Holdings
| Rank | Stock | Shares | Value | % of Portfolio |
|---|---|---|---|---|
| 1 | Kymera Therapeutics, Inc. | 4,659,874 | $362.6M | 41.91% |
| 2 | Dyne Therapeutics, Inc. | 9,130,465 | $178.6M | 20.64% |
| 3 | Sionna Therapeutics, Inc. | 2,995,602 | $123.2M | 14.24% |
| 4 | Disc Medicine, Inc. | 1,513,875 | $120.2M | 13.90% |
| 5 | Day One Biopharmaceuticals, Inc. | 6,412,560 | $59.8M | 6.91% |
| 6 | Korro Bio, Inc. | 1,137,149 | $9.1M | 1.05% |
| 7 | Q32 Bio, Inc. | 2,092,106 | $6.9M | 0.80% |
| 8 | Generation Bio, Co. | 827,946 | $4.7M | 0.54% |
Quarterly Changes
Sector Breakdown
| Sector | # Holdings | Value | % |
|---|---|---|---|
| Healthcare | 8 | $865.1M | 100.0% |